0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe
- RxCUI
- 2613763
- RxNorm name
- 0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe
- Display name
- 0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe
- Full name
- 0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:17
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761173 | Stimufend | pegfilgrastim-fpgk | 351(k) Biosimilar | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STIMUFEND | PEGFLILGRASTIM-FPGK | NORTHSTAR RX LLC | 1e36ee55-7f13-41db-9d49-2f7a92f3b750 | 2025-11-30 | Warnings, Adverse reactions | 2613763 |
| STIMUFEND | PEGFLILGRASTIM-FPGK | Fresenius Kabi USA, LLC | b44bcb82-7e60-4dab-a658-115bdf5c053c | 2023-10-24 | Warnings, Adverse reactions | 2613763 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b44bcb82-7e60-4dab-a658-115bdf5c053c | pegfilgrastim-fpgk 6 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe [SCD] · pegfilgrastim-fpgk 6 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 4 | These highlights do not include all the information needed to use STIMUFEND safely and effectively. See full prescribing information for STIMUFEND. STIMUFEND ® (pegfilgrastim-fpgk) injection, for subcutaneous use Initial U.S. Approval: 2022 STIMUFEND (pegfilgrastim-fpgk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful di | 20231024 |
| 1e36ee55-7f13-41db-9d49-2f7a92f3b750 | pegfilgrastim-fpgk 6 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML pegfilgrastim-fpgk 10 MG/ML Prefilled Syringe [SCD] · pegfilgrastim-fpgk 6 MG per 0.6 ML Prefilled Syringe [SY] | 3 | 1 | These highlights do not include all the information needed to use STIMUFEND safely and effectively. See full prescribing information for STIMUFEND. STIMUFEND ® (pegfilgrastim-fpgk) injection, for subcutaneous use Initial U.S. Approval: 2022 STIMUFEND (pegfilgrastim-fpgk) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful di | 20251130 |